ADVERTISEMENT
ADVERTISEMENT
Discover How Single-Cell Sequencing Can Clarify Tumor Complexity
Molecular-Level Dissection of the Tumor Microenvironment 
An immuno-oncology targeting panel accurately characterized tumor-resident immune cells and located pathologically and clinically relevant tumor microenvironment features. 
Molecular-Level Dissection of the Tumor Microenvironment 
Molecular-Level Dissection of the Tumor Microenvironment 

An immuno-oncology targeting panel accurately characterized tumor-resident immune cells and located pathologically and clinically relevant tumor microenvironment features. 

An immuno-oncology targeting panel accurately characterized tumor-resident immune cells and located pathologically and clinically relevant tumor microenvironment features. 

immuno-oncology

Discover How Immunoassays Deliver Protein Biomarker Research Solutions
Protein Biomarker Research Solutions
The Scientist Creative Services Team in collaboration with MilliporeSigma | Sep 9, 2024 | 1 min read
Immunoassays help researchers across a range of applications from screening to targeted analysis.
Cancer Vaccines: A Dose of Prevention
Cancer Vaccines: A Dose of Prevention
The Scientist | Aug 10, 2023 | 1 min read
Discover the latest progress behind therapeutic vaccines that boost the immune system’s cancer-killing abilities.
Breaking Down Barriers: Cell Therapy for Solid Tumors
The Persistence of (T Cell) Memory: Towards Cellular Therapy for Solid Tumors
The Scientist | Nov 7, 2022 | 1 min read
In this webinar, Douglas Green will describe how early events in T cell activation influence anti-tumor immunity. 
jigsaw puzzle with magnifying glass over the word "metastasis" 
Breast Cancer Cells Retrain T Cells to Invade Specific Tissues
Nele Haelterman, PhD | Sep 26, 2022 | 3 min read
Scientists discover tumor-associated T cells that drive breast cancer metastasis to lymph nodes.
3d illustration proteins with lymphocytes , t cells or cancer cells
New Patient Tumor Cell Models Rapidly Predict Cancer Therapy Outcomes
Jennifer Zieba, PhD | Jul 11, 2022 | 4 min read
A new benchtop microfluidic device generates patient-derived tumor micro-organospheres that allow for real-time cancer therapy decisions.
Identifying Biomarkers to Guide Cancer Immunotherapy
Identifying Biomarkers to Guide Cancer Immunotherapy
The Scientist | Mar 15, 2022 | 2 min read
An expert panel will discuss the cutting-edge technologies they used to identify novel biomarkers that predict patient responses to immunotherapy.
ADVERTISEMENT